Corvus Pharmaceuticals CRVS

$ 9.02 -0.88%

Quarterly report 2024-Q2
added 08-06-2024

Corvus Pharmaceuticals Income Statement 2011-2024 | CRVS

Annual Income Statement Corvus Pharmaceuticals

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	94.1 M	30.7 M	74.1 M	103 M	161 M	107 M	190 M	214 M	-	-	-	-	-
Shares	48 M	46.6 M	41.9 M	29.5 M	29.3 M	27.5 M	20.5 M	15.4 M	-	-	-	-	-
Historical Prices	1.96	0.66	1.77	3.48	3.44	4.84	8.19	14.4	-	-	-	-	-
Net Income	-27 M	-41.3 M	-43.2 M	-6 M	-46.7 M	-46.9 M	-55.7 M	-36.4 M	-31.3 M	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-23.4 M	-32.6 M	-38.6 M	-43.8 M	-48.9 M	-49.2 M	-56.5 M	-37 M	-13.8 M	-161 K	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-23.3 M	-32.2 M	-38.2 M	-43.1 M	-48.1 M	-48.4 M	-55.7 M	-36.4 M	-13.6 M	-	-	-	-
Operating Expenses	23.4 M	32.6 M	38.6 M	43.8 M	48.9 M	49.2 M	56.5 M	37 M	-	-	-	-	-
General and Administrative Expenses	6.88 M	8.1 M	9.52 M	11.9 M	10.9 M	10.6 M	10.2 M	7.62 M	2.42 M	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Corvus Pharmaceuticals

	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	59.7 M	49 M	49 M	49 M	47.5 M	46.6 M	46.6 M	46.6 M	46.6 M	46.6 M	46.6 M	43.9 M	42.2 M	34.5 M	28.4 M	29.5 M	29.4 M	29.4 M	28 M	29.4 M	29.3 M	29.3 M	29.3 M	29.1 M	29 M	22.6 M	21 M	20.5 M	20.4 M	20.3 M	20.9 M	20.2 M	20 M	1.18 M	1.43 M	395 K	346 K	297 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-4.26 M	-5.7 M	-	-6 M	-6.5 M	-7.87 M	-	-14.8 M	-8.36 M	-8.3 M	-	-10.7 M	-11.8 M	-11.6 M	27.3 M	-9.8 M	-10.6 M	-12.9 M	-11 M	-11 M	-13 M	-11.6 M	-10.5 M	-10.5 M	-11.6 M	-14.3 M	-11.9 M	-12.7 M	-15 M	-16 M	-11.1 M	-10.3 M	-8.64 M	-6.35 M	-6.04 M	-3.15 M	-20.2 M	-1.91 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-5.94 M	-6.25 M	-	-5.56 M	-5.62 M	-6.57 M	-	-12.5 M	-7.01 M	-7.41 M	-	-9.05 M	-11.3 M	-11.5 M	-	-9.84 M	-10.8 M	-13.3 M	-	-11.5 M	-13.6 M	-12.3 M	-	-11.1 M	-12.3 M	-14.6 M	-	-12.9 M	-15.2 M	-16.2 M	-	-10.5 M	-8.82 M	-6.43 M	-	-3.12 M	-2.33 M	-2.21 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-5.91 M	-6.23 M	-	-5.53 M	-5.59 M	-6.52 M	-	-12.4 M	-6.92 M	-7.33 M	-	-8.68 M	-11 M	-11.3 M	-	-9.36 M	-10.4 M	-13.1 M	-	-11 M	-13.2 M	-12.1 M	-	-10.5 M	-11.8 M	-14.4 M	-	-12.3 M	-14.8 M	-16 M	-	-10.1 M	-8.58 M	-6.32 M	-	-3.03 M	-2.3 M	-2.21 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	5.94 M	6.25 M	-	5.56 M	5.62 M	6.57 M	-	12.5 M	7.01 M	7.41 M	6.81 M	9.05 M	11.3 M	11.5 M	9.88 M	9.84 M	10.8 M	13.3 M	11.4 M	11.5 M	13.6 M	12.3 M	11.2 M	11.1 M	12.3 M	14.6 M	12.2 M	12.9 M	15.2 M	16.2 M	11.2 M	10.5 M	8.82 M	6.43 M	-	-	2.33 M	2.21 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	1.82 M	2.18 M	-	1.6 M	1.65 M	1.98 M	-	2.11 M	2.09 M	2.31 M	-	2.06 M	2.18 M	3.25 M	-	3.23 M	2.91 M	3.11 M	-	2.52 M	2.96 M	2.89 M	-	2.78 M	2.54 M	2.54 M	-	2.21 M	2.79 M	2.72 M	-	2.77 M	1.71 M	1.03 M	-	606 K	327 K	290 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency